Micro-Sphere to boost its spray drying capabilities

28 Oct 2019

CDMO to invest over €3 million in GMP facility expansion.

Spray drying specialist and capsule filling service provider Micro-Sphere is investing 3.5 million CHF (€3.2 million) into expanding its GMP manufacturing capabilities and processes.

Micro-Sphere to boost its spray drying capabilities

Micro-Sphere will add an additional spray drying line to its facility in Switzerland in response to increased market demand for spray drying and capsule filling for dry powder inhalers.

The new production line, expected to be operational by Q1 2021, is Micro-Sphere’s fifth and will allow the CDMO to handle larger quantities of pharmaceutical powders and commercial volumes of finished dosage forms.

Commenting on the investment, Michael Grassberger, Managing Director at Micro-Sphere said: “Our decision to invest has been fuelled by greater demand for spray drying services and we expect it will generate significant benefits for our clients. Our flexibility is key to our success and this investment allows us to maintain that competitive advantage.”

The Swiss facility, already home to some of the world’s leading spray drying and capsule filling technologies, will also benefit from the introduction of a new enterprise resource planning (ERP) system and ‘Chromeleon’ a Chromatografy Data System (CDS) software to support the QC Lab workflow.

Both software systems will bring significant cost and time savings to the business and streamline process efficiency.

Michael Grassberger added: “This year we have focused on making the necessary investments to prepare Micro-Sphere for growth in 2019 and beyond. As well as investing in new machinery to increase our capabilities and expertise, we have also made significant investment into the latest technology. This includes investing in software platforms to ensure the most efficient and robust quality and documentation management systems are in place.

“At Micro-Sphere we’re committed to client satisfaction and ensuring our customers continue to receive the efficient and flexible service that they’re used to, so we’re always looking for ways to further improve our operations to allow us to better cater for their projects.

“This investment further demonstrates our commitment to meeting and exceeding the expectations of our customers and our experienced team are very excited to bring these investments into operation.”

Read More

Related news

Recipharm expands Indian injectable dosage form capabilities

Recipharm expands Indian injectable dosage form capabilities

7 Nov 2019

Partnership will combine capabilities and expertise in Europe and India to build a new facility dedicated to injectable formulations to supply demand from Europe and overseas territories.

Read more 
Aptar acquires a leader in drug delivery training devices and patient onboarding

Aptar acquires a leader in drug delivery training devices and patient onboarding

6 Nov 2019

Acquisition reflects movement of treatments being administered by patients at home rather than by healthcare providers.

Read more 
Europe predicted to surpass the US in biologic manufacturing capacity by 2023

Europe predicted to surpass the US in biologic manufacturing capacity by 2023

6 Nov 2019

Demand for biological manufacturing is growing faster than capacity growth.

Read more 
SP acquires Spain based global provider of complete sterile filling lines

SP acquires Spain based global provider of complete sterile filling lines

5 Nov 2019

Company's strategic move reflects its expectation of short-run aseptic liquid filling to continue to drive pharmaceutical growth.

Read more 
Legacy recruits heavily to meet growing steriles demand

Legacy recruits heavily to meet growing steriles demand

5 Nov 2019

Company to reach 250 employees by year end to meet growing drug product manufacturing demand.

Read more 
China on course for 'massive' bio capacity shortfall

China on course for 'massive' bio capacity shortfall

4 Nov 2019

A shortage of qualified personnel may be a drag factor in cell and gene therapies; in China 100,00L of capacity will need to be added every year to meet bio demand.

Read more 
Recipharm launches new service to support companies with QC and analytical requirements

Recipharm launches new service to support companies with QC and analytical requirements

1 Nov 2019

Services including method development, method validation, and stability program design and implementation.

Read more 
Evonetix expands to develop its desktop DNA synthesis platform

Evonetix expands to develop its desktop DNA synthesis platform

31 Oct 2019

15,000 sq. ft of laboratory and office space will enable continued growth and development of the company’s integrated desktop platform for DNA synthesis.

Read more 
The way forward? Collaborate with robots

The way forward? Collaborate with robots

30 Oct 2019

Vetter increasingly relies on close interaction of humans and machines for greater flexibility.

Read more 
The benefits of transitioning from paper-based to paperless batch record management

The benefits of transitioning from paper-based to paperless batch record management

29 Oct 2019

Free webinar to discuss the benefits of a collaborative approach to implementing an electronic batch record platform.

Read more